Robyn Sayner1, Delesha M Carpenter2, Alan L Robin3,4, Susan J Blalock1, Kelly W Muir5, Michelle Vitko1, Mary Elizabeth Hartnett6, Scott D Lawrence7, Annette L Giangiacomo8, Gail Tudor9, Jason A Goldsmith6, Betsy Sleath1,10. 1. Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 2. Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Asheville, NC, USA. 3. Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, MD, USA. 4. Department of International Health, Bloomberg School of Public Health, Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. 5. Department of Ophthalmology, School of Medicine, Duke University, Durham, NC, USA. 6. Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA. 7. Glaucoma Service, University of North Carolina Kittner Eye Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 8. Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA. 9. Department of Science and Mathematics, Institutional Research, Husson University, Bangor, ME, USA. 10. Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract
OBJECTIVES: The objective of this study was to examine the extent to which patient characteristics, eye drop technique self-efficacy, and ophthalmologist-patient communication about eye drop administration are associated with glaucoma patients' ability to instil a single drop, have the drop land in the eye, and avoid touching the applicator tip of the medication bottle to the eye or face while self-administering eye drops. METHODS: Glaucoma patients (n = 279) were recruited from six ophthalmology clinics. Medical visits were videotape-recorded. Afterwards, patients were interviewed and demonstrated administering an eye drop on a videotaped-recording. Generalized estimating equations were used to analyse the data. KEY FINDINGS: Ophthalmologists provided eye drop administration instruction to 40 patients. Patients with more years of education were significantly more likely to both instil a single drop (P = 0.017) and have the drop land in their eye (P = 0.017). Women were significantly more likely to touch the applicator tip to their eyes or face (P = 0.014). Patients with severe glaucoma (P = 0.016), women (P = 0.026), and patients who asked at least one eye drop administration question (P = 0.001) were significantly less likely to instil a single drop. Patients with arthritis were significantly less likely to have the drop land in their eye (P = 0.008). African American patients were significantly less likely to touch the applicator tip to their eyes or face (P = 0.008). CONCLUSIONS: Some glaucoma patients have a difficult time self-administering eye drops. As so few patients received eye drop administration instruction from their providers, there is an opportunity for pharmacists to complement care.
OBJECTIVES: The objective of this study was to examine the extent to which patient characteristics, eye drop technique self-efficacy, and ophthalmologist-patient communication about eye drop administration are associated with glaucomapatients' ability to instil a single drop, have the drop land in the eye, and avoid touching the applicator tip of the medication bottle to the eye or face while self-administering eye drops. METHODS:Glaucomapatients (n = 279) were recruited from six ophthalmology clinics. Medical visits were videotape-recorded. Afterwards, patients were interviewed and demonstrated administering an eye drop on a videotaped-recording. Generalized estimating equations were used to analyse the data. KEY FINDINGS: Ophthalmologists provided eye drop administration instruction to 40 patients. Patients with more years of education were significantly more likely to both instil a single drop (P = 0.017) and have the drop land in their eye (P = 0.017). Women were significantly more likely to touch the applicator tip to their eyes or face (P = 0.014). Patients with severe glaucoma (P = 0.016), women (P = 0.026), and patients who asked at least one eye drop administration question (P = 0.001) were significantly less likely to instil a single drop. Patients with arthritis were significantly less likely to have the drop land in their eye (P = 0.008). African American patients were significantly less likely to touch the applicator tip to their eyes or face (P = 0.008). CONCLUSIONS: Some glaucomapatients have a difficult time self-administering eye drops. As so few patients received eye drop administration instruction from their providers, there is an opportunity for pharmacists to complement care.
Authors: Betsy Sleath; Susan J Blalock; Jennifer L Stone; Asheley Cockrell Skinner; David Covert; Kelly Muir; Alan L Robin Journal: Br J Ophthalmol Date: 2011-05-24 Impact factor: 4.638
Authors: Betsy Sleath; Susan Blalock; David Covert; Jennifer L Stone; Asheley Cockrell Skinner; Kelly Muir; Alan L Robin Journal: Ophthalmology Date: 2011-12 Impact factor: 12.079
Authors: Bonnie Nga Kwan Choy; Ming Ming Zhu; Jason Chun Sum Pang; Jonathan Cheuk Hung Chan; Alex Lap Ki Ng; Michelle Ching Yim Fan; Lawrence Pui Leung Iu; Joseph Shiu Kwong Kwan; Jimmy Shiu Ming Lai; Patrick Ka Chun Chiu Journal: J Ophthalmol Date: 2019-03-26 Impact factor: 1.909
Authors: Kevin J Schneider; Cecilia N Hollenhorst; Autumn N Valicevic; Leslie M Niziol; Michele Heisler; David C Musch; Stephen M Cain; Paula-Anne Newman-Casey Journal: Ophthalmol Glaucoma Date: 2020-08-08